Zenapax 25mg Injection
Prescription Required
Product introduction
Zenapax 25mg Injection belongs to the immunosuppressant group of medicines. It is used in the treatment of multiple sclerosis.
It is an immunosuppressant
It is an immunosuppressant
Uses of Zenapax Injection
Benefits of Zenapax Injection
In Multiple sclerosis (MS)
Multiple sclerosis (MS) is a disease of the brain and spinal cord in which a person’s own immune system attacks the protective sheath (called myelin) of the nerves. This leads to symptoms such as vision loss, pain, fatigue and improper coordination. Zenapax 25mg Injection helps to suppress the body’s immune system, thereby reducing the progression of the disease. It reduces the inflammation of the damaged nerves, prevents further damage and stabilises your immune system. This medicine is given as an injection by a doctor or nurse and should not be self-administered. Follow your doctor’s instructions carefully to get the best results.
Side effects of Zenapax Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Zenapax
- Upper respiratory tract infection
- Flu-like symptoms
- Dermatitis
- Bronchitis (inflammation of the airways)
- Eczema
- Depression
- Injection site reactions (pain, swelling, redness)
How to use Zenapax Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Zenapax 25mg Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Zenapax 25mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Zenapax 25mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
SAFE
Zenapax 25mg Injection does not usually affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Zenapax 25mg Injection is safe to use in patients with kidney disease. No dose adjustment of Zenapax 25mg Injection is recommended.
Liver
UNSAFE
Zenapax 25mg Injection is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Zenapax 25mg Injection is given as an injection under the skin by the healthcare provider only.
- Your doctor may check your liver function before starting treatment and regularly thereafter. Inform your doctor if you notice yellowing of eyes or skin, dark urine, or stomach pain.
- It reduces the body’s ability to fight with infection. Take caution or inform the doctor if experience respiratory tract infection.
- Inform your doctor if you experience suicidal thoughts or unusual changes in behavior or mood.
- Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.
Fact Box
Chemical Class
Monoclonal antibody (mAb)
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
IL-2 Receptor anatgonist
Patient concerns
FAQs
How does Zenapax 25mg Injection work?
Zenapax 25mg Injection suppresses the activity of the body's immune system (immunosuppressive agent) thereby preventing the rejection of transplanted kidney by body's own immune system.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 979.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 347-48.
- Drugs.com. Daclizumab. [Accessed 06 Apr. 2019] (online) Available from:
- Daclizumab. Nutley, New Jersey: Hoffmann-La Roche inc. [Accessed 06 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 06 Apr. 2019] (online) Available from:
Marketer details
Name: Roche Products India Pvt Ltd
Address: 1503, 15th Floor, ‘The Capital’, Plot no. C-70, Behind ICICI Bank, BKC, Bandra (E) , Mumbai 400051
Country of origin: India
Lab tests offered by us
Related/Popular tests
DISCONTINUED
We do not facilitate sale of this product at present